Spire Healthcare Group (LON:SPI) Shares Down 16.3% – Time to Sell?

Spire Healthcare Group plc (LON:SPI) was down 16.3% on Thursday . The stock traded as low as GBX 169 ($2.18) and last traded at GBX 188 ($2.42). Approximately 4,929,258 shares traded hands during trading, an increase of 648% from the average daily volume of 658,925 shares. The stock had previously closed at GBX 224.50 ($2.89).

Spire Healthcare Group Stock Down 16.3 %

The company has a market capitalization of £754.90 million, a P/E ratio of 26.76, a PEG ratio of 1.06 and a beta of 0.96. The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 62.25. The stock has a 50 day moving average price of GBX 229.09 and a 200 day moving average price of GBX 230.72.

Spire Healthcare Group (LON:SPI) last announced its quarterly earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.11) EPS for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, research analysts anticipate that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.